5 Must-Knows Before Tuesday’s Market Opens

Good morning, and welcome to your daily market briefing. As the trading week unfolds, investors are navigating a complex landscape marked by geopolitical tensions, significant corporate maneuvers, and the relentless march of technological innovation. Here’s what you need to know to start your day.

Following a session where major averages closed higher, stock futures are showing a softer tone this morning, indicating a cautious start to trading. Investors are closely monitoring key developments that could shape market sentiment and sector performance.

The clock is ticking for a potential de-escalation of tensions surrounding the Strait of Hormuz. With President Donald Trump’s 8 p.m. ET deadline for Iran to reopen the critical maritime passage rapidly approaching, hopes for a swift ceasefire deal are diminishing.

Key takeaways:

• President Trump has characterized the latest ceasefire proposal as “not good enough,” despite acknowledging it as a “very significant step.” This indicates a high bar for acceptance and underscores the administration’s stance on Iran’s actions.
• The President has reiterated threats of extensive U.S. military action against Iran’s power infrastructure and transportation networks should the Strait of Hormuz not be reopened by the evening’s deadline. This rhetoric has heightened concerns about potential supply chain disruptions and inflationary pressures.
• Crude oil prices are continuing their upward trajectory today, a direct consequence of the ongoing effective closure of this vital global chokepoint. The market is pricing in the increasing risk premium associated with the potential for further conflict and its impact on global energy supplies.
• In a testament to the market’s heightened focus on this issue, Citrini Research, a Wall Street firm, dispatched an analyst to Oman’s Musandam Peninsula for a firsthand assessment of traffic flow through the Strait. The findings from this on-the-ground report are being closely scrutinized for real-time insights into the Strait’s operational status and the broader economic implications.
• Futures tied to the Dow Jones Industrial Average experienced a notable decline of 200 points in early trading. This downward movement reflects a growing sense of pessimism among investors regarding the likelihood of a U.S.-Iran accord before the President’s ultimatum expires. The market is clearly sensitive to geopolitical uncertainties, and a negative resolution could trigger broader market volatility.

Shares of Universal Music Group surged over 10% today following a significant acquisition proposal from Bill Ackman’s Pershing Square. The activist investor has offered to acquire the music giant in a transaction valued at approximately 55.8 billion euros, or $64.4 billion, comprised of both cash and stock.

This strategic move by Ackman values Universal Music Group at 30.4 euros per share, representing a substantial premium of nearly 80% over its closing share price on April 2. The proposed structure involves the creation of a newly merged entity that would combine with Pershing Square, followed by a listing on the New York Stock Exchange – a long-standing objective for Ackman.

In a statement, Ackman articulated that UMG’s stock performance has been “languished” due to external factors unrelated to the core strength of its music business. He believes these issues are addressable through the proposed transaction, suggesting that the market has been undervaluing the company’s intrinsic worth. Prior to this announcement, UMG shares had experienced a 23% decline year-to-date, highlighting a significant disconnect between the company’s operational performance and its market valuation.

With the trial date between OpenAI and Elon Musk rapidly approaching, the artificial intelligence powerhouse is launching a strategic offensive. OpenAI has formally requested that the Attorneys General of Delaware and California initiate investigations into Musk’s alleged “improper and anti-competitive behavior.” This move signals a significant escalation in the high-stakes legal dispute.

The letter from OpenAI directly accuses the Tesla CEO, who was instrumental in co-founding OpenAI before departing in 2018, of orchestrating his actions in concert with Meta CEO Mark Zuckerberg. This assertion suggests a perceived strategic alignment between Musk and Meta, potentially aimed at undermining OpenAI’s competitive position.

This is not the first instance of OpenAI acknowledging Musk’s potential impact on its business operations. Since Musk initiated his lawsuit against OpenAI in 2024, the company has consistently warned investors about the possibility of “deliberately outlandish, attention-grabbing claims” being made by Musk leading up to the trial. Jury selection is slated to commence later this month, intensifying the focus on this pivotal legal contest and its implications for the future of AI development and competition.

Shares of Broadcom are trading up 3% in pre-market activity following the semiconductor giant’s disclosure of significant new agreements with Google and Anthropic. These deals underscore the robust and sustained demand for the critical infrastructure required to power the ongoing artificial intelligence revolution.

Under the terms of the expanded partnership with Google, Broadcom will be responsible for manufacturing future iterations of the tech behemoth’s proprietary AI chips. Furthermore, the agreement grants Anthropic access to approximately 3.5 gigawatts of computing capacity, representing a substantial expansion of its existing collaborations with both Google and the AI startup. This integrated approach to AI hardware and computing power suggests a strategic effort to accelerate AI development and deployment.

Anthropic reported in a blog post on Monday that its annualized revenue has now surpassed $30 billion, a remarkable leap from approximately $9 billion at the close of the previous year. This explosive revenue growth highlights the immense commercialization potential of advanced AI models and the critical role that companies like Broadcom play in enabling this expansion. The deals signify a significant validation of Broadcom’s technological capabilities and its strategic positioning within the rapidly evolving AI ecosystem.

Novo Nordisk has experienced an unprecedented surge in demand for its oral formulation of Wegovy since its launch three months ago. This remarkable uptake is largely attributed to a new cohort of patients who are embracing this less invasive treatment option for obesity.

The Wegovy pill, which secured the distinction of being the first GLP-1 pill for obesity in January, offers distinct advantages over its injectable predecessor. Beyond its potentially lower cost, the oral pill eliminates the need for needles, a significant deterrent for a segment of the patient population. As Jamey Millar, Novo Nordisk’s head of U.S. operations, noted last week, the company is now appealing to patients who are averse to both the needle-stick experience and potentially high price points associated with injectable treatments. This dual appeal is crucial in broadening market penetration.

Despite the overwhelming demand for the Wegovy pill, Novo Nordisk’s stock performance has yet to fully reflect this success. The Danish pharmaceutical giant faces intense competition in the lucrative obesity market, particularly from Eli Lilly. Eli Lilly recently received U.S. approval for its own GLP-1 pill, intensifying the competitive landscape and highlighting the ongoing race for market share in this rapidly expanding therapeutic area.

JPMorgan Chase CEO Jamie Dimon, in his annual shareholder letter released yesterday, outlined a series of “significant” challenges confronting his institution. These include the pervasive influence of geopolitics, the transformative potential and risks of artificial intelligence, and the inherent volatility within private markets. However, Dimon reserved particular criticism for what he characterized as “poor bank regulations,” suggesting a need for recalibration in the regulatory landscape.